As of February 10, 2026, C3.ai (NYSE: AI) is quietly regaining its footing after a bruising start to the year. Following a sharp sell-off that pushed the stock to a 52-week low of $10.19 in early February, shares have rebounded by roughly 14%, recently closing near $11.64. While volatility remains elevated, this recovery has reignited a familiar question among investors: is this merely a short-lived bounce, or the early stages of a genuine breakout for one of enterprise AI’s most closely watched players?
Market sentiment currently sits at the crossroads of cautious optimism and hard-nosed skepticism. According to recent earnings call transcripts, C3.ai exceeded expectations in fiscal Q2, reporting a loss of $0.25 per share versus the $0.33 analysts had forecast. Still, translating this operational progress into a sustained stock rally in 2026 will hinge on execution — particularly in federal contracts and an increasingly competitive global AI landscape.
1. Federal Contracts: The Core of C3.ai’s Strategic Moat
A key pillar of the bullish thesis lies in C3.ai’s growing dominance within the public sector. The company recently disclosed that federal bookings surged 89% year-over-year, now representing nearly 45% of total bookings. Momentum accelerated further on February 6, 2026, when reports emerged of a landmark $500 million U.S. Department of Defense contract aimed at scaling AI-powered modeling and simulation capabilities.
This expansion into “Contested Logistics” for the U.S. Army and allied agencies offers C3.ai a revenue stream that is structurally more stable than traditional enterprise software spending. Importantly, this trend is not limited to the United States. Governments worldwide are accelerating investments in “sovereign AI” to protect critical infrastructure and national security. A broader perspective on this geopolitical shift can be found in our analysis of the intensifying U.S.–China AI race.
2. All Eyes on Fiscal Q3 2026
Attention now turns squarely to C3.ai’s upcoming fiscal third-quarter earnings report, expected in late February or early March 2026. Management has guided for revenue between $72 million and $80 million. For the stock to decisively break higher, investors will need evidence that the company’s expanding Agentic AI pipeline is converting into measurable, recurring revenue.
Specifically, the market will be watching for:
- Deeper traction within the partner ecosystem, particularly with Microsoft Azure and AWS, which currently account for over 80% of new bookings.
- Signs of margin stabilization as C3.ai continues shifting toward a consumption-based pricing model.
- Concrete updates on the deployment of autonomous AI agents, an area where industrial AI applications are rapidly becoming the benchmark for operational efficiency.
3. Persistent Headwinds: Insider Activity and Investor Doubt
Despite the recent rebound, not all signals are flashing green. Recent SEC filings reveal that Executive Chairman Thomas M. Siebel sold approximately 27,605 shares on February 2, 2026. While the sales were primarily tied to tax obligations following the vesting of restricted stock units (RSUs), insider selling during periods of price weakness often draws heightened scrutiny from retail investors.
Institutional sentiment remains sharply divided as well. BofA Securities recently cut its price target to $10, citing execution and adoption risks, while other analysts continue to project upside targets ranging from $17 to $24, reflecting confidence in C3.ai’s long-term role within generative and agent-based AI. Overlaying all of this are broader concerns around AI chip supply constraints and regulatory uncertainty — issues we explore in depth in our coverage of how 2026 regulations are reshaping technology valuations.
The Bottom Line: A Breakout or a Pause?
So, is the breakout real? Fundamentally, C3.ai appears better positioned today than it was six months ago, supported by its strategic pivot toward Agentic AI and its increasingly entrenched role in the defense sector. That said, confirmation will require more than a bounce. The stock must decisively clear the $13.00 resistance level on strong volume and deliver a Q3 earnings report that demonstrates a credible path toward non-GAAP profitability.
For now, the 14% rebound reflects renewed confidence — but the definitive verdict will arrive with the company’s next earnings release.
—
This C3.ai Q2 FY2026 earnings analysis highlights the surge in federal bookings that currently underpins the stock’s recovery narrative.
